866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Insulin Glargine Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Insulin

No. of Pages : 100 Pages

In this report, the EMEA Insulin Glargine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (M ml), revenue (Million USD), market share and growth rate of Insulin Glargine for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Insulin Glargine market competition by top manufacturers/players, with Insulin Glargine sales volume (M ml), price (USD/ml), revenue (Million USD) and market share for each manufacturer/player; the top players including
Sanofi-Aventis
Ganlee
Biocon
...

On the basis of product, this report displays the sales volume (M ml), revenue (Million USD), product price (USD/ml), market share and growth rate of each type, primarily split into
Single Dose Vial
Pre-filled Syringe

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (M ml), market share and growth rate of Insulin Glargine for each application, including
Treat Type 1 Diabetes
Treat Type 2 Diabetes
Table of Contents

EMEA (Europe, Middle East and Africa) Insulin Glargine Market Report 2017
1 Insulin Glargine Overview
1.1 Product Overview and Scope of Insulin Glargine
1.2 Classification of Insulin Glargine
1.2.1 EMEA Insulin Glargine Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Insulin Glargine Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Single Dose Vial
1.2.4 Pre-filled Syringe
1.3 EMEA Insulin Glargine Market by Application/End Users
1.3.1 EMEA Insulin Glargine Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Treat Type 1 Diabetes
1.3.3 Treat Type 2 Diabetes
1.4 EMEA Insulin Glargine Market by Region
1.4.1 EMEA Insulin Glargine Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Insulin Glargine (2012-2022)
1.5.1 EMEA Insulin Glargine Sales and Growth Rate (2012-2022)
1.5.2 EMEA Insulin Glargine Revenue and Growth Rate (2012-2022)

2 EMEA Insulin Glargine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Insulin Glargine Market Competition by Players/Manufacturers
2.1.1 EMEA Insulin Glargine Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Insulin Glargine Revenue and Share by Players (2012-2017)
2.1.3 EMEA Insulin Glargine Sale Price by Players (2012-2017)
2.2 EMEA Insulin Glargine (Volume and Value) by Type/Product Category
2.2.1 EMEA Insulin Glargine Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Insulin Glargine Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Insulin Glargine Sale Price by Type (2012-2017)
2.3 EMEA Insulin Glargine (Volume) by Application
2.4 EMEA Insulin Glargine (Volume and Value) by Region
2.4.1 EMEA Insulin Glargine Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Insulin Glargine Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Insulin Glargine Sales Price by Region (2012-2017)

3 Europe Insulin Glargine (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Insulin Glargine Sales and Value (2012-2017)
3.1.1 Europe Insulin Glargine Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Insulin Glargine Revenue and Growth Rate (2012-2017)
3.2 Europe Insulin Glargine Sales and Market Share by Type
3.3 Europe Insulin Glargine Sales and Market Share by Application
3.4 Europe Insulin Glargine Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Insulin Glargine Sales Volume by Countries (2012-2017)
3.4.2 Europe Insulin Glargine Revenue by Countries (2012-2017)
3.4.3 Germany Insulin Glargine Sales and Growth Rate (2012-2017)
3.4.4 France Insulin Glargine Sales and Growth Rate (2012-2017)
3.4.5 UK Insulin Glargine Sales and Growth Rate (2012-2017)
3.4.6 Russia Insulin Glargine Sales and Growth Rate (2012-2017)
3.4.7 Italy Insulin Glargine Sales and Growth Rate (2012-2017)
3.4.8 Benelux Insulin Glargine Sales and Growth Rate (2012-2017)

4 Middle East Insulin Glargine (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Insulin Glargine Sales and Value (2012-2017)
4.1.1 Middle East Insulin Glargine Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Insulin Glargine Revenue and Growth Rate (2012-2017)
4.2 Middle East Insulin Glargine Sales and Market Share by Type
4.3 Middle East Insulin Glargine Sales and Market Share by Application
4.4 Middle East Insulin Glargine Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Insulin Glargine Sales Volume by Countries (2012-2017)
4.4.2 Middle East Insulin Glargine Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Insulin Glargine Sales and Growth Rate (2012-2017)
4.4.4 Israel Insulin Glargine Sales and Growth Rate (2012-2017)
4.4.5 UAE Insulin Glargine Sales and Growth Rate (2012-2017)
4.4.6 Iran Insulin Glargine Sales and Growth Rate (2012-2017)

5 Africa Insulin Glargine (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Insulin Glargine Sales and Value (2012-2017)
5.1.1 Africa Insulin Glargine Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Insulin Glargine Revenue and Growth Rate (2012-2017)
5.2 Africa Insulin Glargine Sales and Market Share by Type
5.3 Africa Insulin Glargine Sales and Market Share by Application
5.4 Africa Insulin Glargine Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Insulin Glargine Sales Volume by Countries (2012-2017)
5.4.2 Africa Insulin Glargine Revenue by Countries (2012-2017)
5.4.3 South Africa Insulin Glargine Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Insulin Glargine Sales and Growth Rate (2012-2017)
5.4.5 Egypt Insulin Glargine Sales and Growth Rate (2012-2017)
5.4.6 Algeria Insulin Glargine Sales and Growth Rate (2012-2017)

6 EMEA Insulin Glargine Manufacturers/Players Profiles and Sales Data
6.1 Sanofi-Aventis
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Insulin Glargine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Ganlee
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Insulin Glargine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Ganlee Insulin Glargine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Biocon
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Insulin Glargine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Biocon Insulin Glargine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
...

7 Insulin Glargine Manufacturing Cost Analysis
7.1 Insulin Glargine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Insulin Glargine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Insulin Glargine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Insulin Glargine Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Insulin Glargine Market Forecast (2017-2022)
11.1 EMEA Insulin Glargine Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Insulin Glargine Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Insulin Glargine Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Insulin Glargine Price and Trend Forecast (2017-2022)
11.2 EMEA Insulin Glargine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Insulin Glargine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Insulin Glargine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Insulin Glargine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Insulin Glargine Sales Forecast by Type (2017-2022)
11.7 EMEA Insulin Glargine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *